Living donor kidney transplantation.
Living donor kidney transplantation is the optimum treatment for the uremic patient. Successful kidney transplantations started in 1953 in Boston and in Sweden in 1964. This article showed data on the selection of the donor, surgical techniques for the removal of the kidney, and follow-up of short-term complications. The long-term results included the number of donors who developed hypertension and the few donors who developed end-stage renal failure (ESRF) and the reasons for this. Finally, new groups of donors such as blood group-incompatible donors and anonymous donors have been accepted, each of whom have their own programs. This article also discussed our responsibilities as renal specialists or transplant surgeons for kidney donors at surgery and postsurgery.
Fehrman-Ekholm
I
I
Dept of Transplantation and Liver Surgery, Sahlgrenska University Hospital, Göteborg, Sweden. ingela.fehrman@sophiahemmet.se
D001787:Blood Group Incompatibility; D005500:Follow-Up Studies; D006801:Humans; D006973:Hypertension / Q000453:epidemiology; D007676:Kidney Failure, Chronic / Q000453:epidemiology; D019520:Living Donors; D009392:Nephrectomy / Q000009:adverse effects / Q000379:methods*; D018579:Patient Selection; D011183:Postoperative Complications / Q000145:classification / Q000453:epidemiology; D012077:Renal Artery / Q000002:abnormalities; D020858:Tissue and Organ Harvesting / Q000009:adverse effects / Q000379:methods*; D016896:Treatment Outcome